The National Comprehensive Cancer Network (NCCN)

What The National Comprehensive Cancer Network (NCCN) does

The National Comprehensive Cancer Network (NCCN) is a not-for-profit alliance of 34 leading U.S. cancer centers founded in 1995 and headquartered in Plymouth Meeting, Pennsylvania, with 51–100 employees. The organization develops and disseminates the NCCN Clinical Practice Guidelines in Oncology, covering 91 cancer topics from acute leukemia to vulvar cancer, and is recognized by CMS and major insurers including UnitedHealthcare as an authoritative reference for oncology coverage policy. The product portfolio includes the Drugs & Biologics Compendium, Biomarkers Compendium, Radiation Therapy Compendium, Chemotherapy Order Templates, Evidence Blocks, and the Framework for Resource Stratification, supported by digital platforms such as NCCN Guidelines Navigator and NCCN Guidelines in Practice, plus iOS and Android mobile apps.

NCCN generates revenue through institutional subscriptions to Compendia and Templates, continuing education programs delivering over 210 accredited activities annually, site licenses for EHR-integrated Templates, the NCCN Foundation donations pipeline, and pharma-funded research grants routed through the Oncology Research Program. The NCCN Foundation, a 501(c)(3), has awarded over $11 million in Young Investigator Awards since 2011. Global reach spans 190+ countries, with 57 Sub-Saharan Africa adaptations endorsed by 9 ministries of health, 13 MENA region adaptations via a regional coordinating center, Vietnam partnership with K Hospital, and free patient guidelines in 70+ languages accessed by over 2.1 million users in 2025. Recent strategic moves include the 2025 digital product launches, the May 2026 incorporation of the first AI tool (Clairity Breast) into national oncology guidelines, a senior leadership refresh with new CMO and CSO appointments in 2026, and ongoing pharma-funded research grant expansion.

Name

The National Comprehensive Cancer Network (NCCN)

Legal name

National Comprehensive Cancer Network, Inc.

Website

https://nccn.org

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

51–100 employees

Short description

NCCN is a not-for-profit alliance of 34 leading U.S. cancer centers that develops evidence-based clinical practice guidelines covering 91 cancer topics, distributed to oncology providers, payers, and patients across 190+ countries through subscriptions, CE programs, and free multilingual resources.

Ownership category

akta.pro rank

Product category

Clinical Practice Guidelines

NAICS

Other Scientific and Technical Consulting Services (54169), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Chronic Disease & NCD Program Evaluation (e.g., diabetes/CVD/cancer) (HLAJANAG)

akta.pro secondary industries

Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Clinical practice guidelines
• Oncology decision support
• Cancer treatment standards
• Continuing medical education
• Patient education resources

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Subscription Services: Annual subscriptions for NCCN Compendia (Drugs & Biologics, Biomarkers, Radiation Therapy, Imaging AUC) and NCCN Templates (Chemotherapy Order Templates) providing access to clinical decision support content for healthcare organizations and providers.
2. Donations and Philanthropy: NCCN Foundation accepts donations to fund development and distribution of free patient education resources (NCCN Guidelines for Patients) and Young Investigator Awards for cancer research.
3. Continuing Education Programs: Accredited CE programs including Annual Conference recordings, Guidelines in Practice subscriptions, and educational activities offering CME/CE credits for oncology professionals.
4. Site Licenses: Health Information Technology licenses allowing integration of NCCN Templates content into on-site EHR systems for participating healthcare organizations.

Pricing tiers

Go-to-market motion1 record

Distribution channels7 records

Marketing channels10 records

Core offering

NCCN is a not-for-profit alliance of leading academic cancer centers that develops, continuously updates, and disseminates evidence-based clinical practice guidelines covering 91 cancer topics, supported by clinical decision-support compendia, chemotherapy order templates, and a multilingual patient guideline library. Its products are distributed through digital platforms (nccn.org, mobile apps, Guidelines Navigator) and via institutional subscriptions, site licenses for EHR integration, and continuing-education programs for oncology professionals.

Product overview

NCCN is a nonprofit alliance of 34 leading cancer centers that develops and distributes evidence-based clinical practice guidelines and related resources for cancer care. The core offering consists of NCCN Guidelines covering nearly all cancer types, accompanied by patient-facing versions (NCCN Guidelines for Patients) available in multiple languages. The organization maintains a suite of clinical decision-support tools including the NCCN Drugs & Biologics Compendium, NCCN Biomarkers Compendium, NCCN Radiation Therapy Compendium, NCCN Templates (Chemotherapy Order Templates), NCCN Evidence Blocks, and NCCN Framework for resource stratification. Digital platforms include the NCCN Guidelines Navigator (interactive search tool) and NCCN Guidelines in Practice (continuing education platform). NCCN also offers AI-based tools like Clairity Breast for breast cancer risk assessment, screening tools like the NCCN Distress Thermometer, research funding through the Oncology Research Program, and international adaptations including Harmonized Guidelines for Sub-Saharan Africa. The organization publishes JNCCN journal and provides continuing education for oncology professionals through conferences and activities.

Differentiator

Problem solved

Functional benefit

Brands

• JNCCN: Journal of the National Comprehensive Cancer Network - peer-reviewed medical journal publishing oncology research and clinical practice guidelines
• NCCN Foundation
• NCCN Oncology Research Program
• NCCN Guidelines Navigator
• NCCN Guidelines in Practice
• NCCN Advocacy Academy

Quantifiable outcome

• Cancer treatment inaccessibility in Sub-Saharan Africa reduced from 82% to 54% between 2017-2024 through NCCN guideline adaptations
• +2 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Vietnam National Cancer Hospital (K Hospital)coreStrategic or Co-development Partner · 1 January 2023Partnership established in 2023 with memorandum of understanding to publish NCCN Guidelines adaptations for Vietnam. Expanded from lung and liver cancers to include breast and ovarian cancer adaptations, with plans for colorectal, stomach, and other cancer guidelines. Freely available regionally customized guidelines serve as foundation for training, research, and harmonizing cancer treatment practices with global standards.
• Allied Against Cancer (with American Cancer Society, Clinton Health Access Initiative, IBM)coreStrategic or Co-development Partner · 1 January 2019Alliance announced in 2019 to continue efforts to improve access to high-quality cancer care and treatment in Sub-Saharan Africa through collaborative resource sharing and guideline implementation.
• African Cancer CoalitioncoreStrategic or Co-development Partner · 1 January 2017Long-standing partnership since 2017 to develop 57 NCCN Guideline adaptations for Sub-Saharan Africa covering over 85% of the region's cancer burden. The adaptations have been downloaded by over 76,000 unique users and endorsed by 9 ministries of health. Joint recipients of the 2026 NCCN Partners in Care Award.
• American Cancer SocietycoreStrategic or Co-development Partner · 1 January 2017Collaborative partnership with NCCN and African Cancer Coalition since 2017 to produce international guideline adaptations for Sub-Saharan Africa, downloaded over 120,000 times by over 76,000 unique users. Joint recipients of the 2026 NCCN Partners in Care Award.
• UC Davis Comprehensive Cancer CenterminorStrategic or Co-development PartnerRecipient of $250,000 NCCN Oncology Research Program grant funded by Novartis to launch EMBRACE initiative combining mobile screening with community-driven education and patient navigation services.
• MENA-NCCN Regional Coordinating CentercoreStrategic or Co-development PartnerRegional coordination center leading efforts to adapt 13 NCCN guidelines biannually for the Middle East and North Africa region, honored at NCCN 2026 Annual Conference.
• Saudi Arabia Ministry of National Guard-Health AffairsminorStrategic or Co-development PartnerInternational partnership for adapting clinical guidelines for resource-limited settings, showcased at NCCN 2026 Annual Conference alongside Sub-Saharan Africa initiatives.

Scale indicators14 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• UpToDate (Wolters Kluwer): UpToDate is a subscription clinical decision-support resource used at the point of care by physicians worldwide, directly competing with NCCN Guidelines and Compendia for oncologists' clinical reference spend. Both are evidence-based, paid physician tools aimed at the same oncology decision points.
• American Society of Clinical Oncology (ASCO): ASCO is the leading US oncology professional society publishing its own clinical practice guidelines, ASCO Guidelines, and patient information, directly overlapping NCCN's clinical guideline franchise. ASCO also offers continuing education and member-driven content for oncology professionals, the same customer base NCCN serves.
• European Society for Medical Oncology (ESMO): ESMO is the European counterpart producing ESMO Clinical Practice Guidelines for oncology and serving the same oncologist audience globally. Together with NCCN Harmonized Guidelines and MENA adaptations, ESMO is the most direct international peer to NCCN's guideline-distribution franchise.
• DynaMed (EBSCO): DynaMed is a clinical reference tool providing evidence-based, point-of-care summaries for clinicians, competing for hospital and individual oncologist subscriptions against NCCN Compendia and Guidelines. It is a direct functional peer in evidence-based clinical decision support.
• ClinicalPath (Elsevier): ClinicalPath (formerly Via Oncology) provides oncology decision-support pathways integrated into EHR workflows, directly competing with NCCN Templates site licenses and Compendia integration. Both deliver chemotherapy-order decision support for practicing oncologists.

Broad incumbents

• ClinicalKey (Elsevier): ClinicalKey is Elsevier's broad clinical reference platform covering many specialties beyond oncology, used by hospitals and clinicians for evidence-based content. It overlaps with NCCN's clinical reference use cases but lacks the oncology depth and payer recognition of NCCN Compendia.

Emerging players

• Lexicomp (Wolters Kluwer): Lexicomp is a drug information and clinical reference resource used at the point of care; it overlaps with the NCCN Drugs & Biologics Compendium for oncology medication decision support. It is broader than NCCN's Compendia (general drug information) but intersecting for oncology therapeutics.

Others

• National Cancer Institute (NCI): NCI is the US government cancer research and information agency, producing PDQ Cancer Information Summaries and treatment references that parallel NCCN Guidelines. It is an adjacent/thematic peer in oncology knowledge dissemination rather than a paid subscription competitor.
• American Cancer Society (ACS): ACS is a nonprofit providing cancer patient education, advocacy, and patient-facing resources that overlap with NCCN Guidelines for Patients. ACS also co-produces international guideline adaptations in Sub-Saharan Africa with NCCN, making it both an indirect peer in patient education and a strategic partner.

Regional players

• National Cancer Grid (India): National Cancer Grid is an Indian network of cancer centers producing region-specific cancer care guidelines and standardizing oncology practice in India. It is comparable as a multi-center oncology guideline consortium, and competes with NCCN in serving international healthcare systems outside the US.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/nccn
• Facebookfacebook.com/National.Comprehensive.Cancer.Network
• YouTubeyoutube.com/user/nccnchannel
• Xx.com/nccnnews

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The National Comprehensive Cancer Network (NCCN)